LinkedInFacebookXYouTube

Sven Cohadzic

About Sven Cohadzic

Sven is an accomplished professional with a diverse background spanning International Business, Qualitative Finance, and Real Estate. After earning his degrees from the Rochester Institute of Technology and Zagreb School of Economics and Management, Sven transitioned into the life sciences industry, joining Cyntegrity in 2022. As a Clinical Product Manager, he oversees the development of Cyntegrity's open data visualizers and popular mindsON e-courses while also serving as a key strategist for data-centric marketing approaches. His unique blend of business acumen, tech-savvy, and data analysis expertise has made him an integral part of Cyntegrity's innovation in risk-based quality management for clinical trials.
Sep 2023

Vanguard vs. Big Pharma: Research Focus & Recruitment

By |2024-06-07T14:29:51+02:00September 4, 2023|M&A Insights and Solutions, News|Comments Off on Vanguard vs. Big Pharma: Research Focus & Recruitment

Explore how Vanguard companies, innovative small pharma entities, differ in research focus and recruitment dynamics from larger Pharma.

Read More
May 2023

eyesON | Decentralized Clinical Trials Outlook: USA

By |2023-06-21T17:28:49+02:00May 29, 2023|Interactive Data Visualizations, News|Comments Off on eyesON | Decentralized Clinical Trials Outlook: USA

Data visualization tool designed to identify untapped opportunities for Decentralized Clinical Trials advancement in the oncology sector in the USA.

Read More
May 2023

Big Pharma M&As: Is It Worth the Trouble?

By |2024-06-07T14:30:31+02:00May 10, 2023|Blog, M&A Insights and Solutions, News|Comments Off on Big Pharma M&As: Is It Worth the Trouble?

Big Pharma M&As: A Worthwhile Challenge? Navigating the complex landscape of M&As in the pharmaceutical industry comes with unique objectives and potential benefits. But do these transactions truly drive shareholder value for the acquiring firm?

Read More
Apr 2023

eyesON | Big Pharma M&As: Clinical Trials Data Visualization

By |2024-06-07T15:20:19+02:00April 25, 2023|Interactive Data Visualizations, M&A Insights and Solutions, News|Comments Off on eyesON | Big Pharma M&As: Clinical Trials Data Visualization

Users can explore the impact of M&As on pharma companies, by examining how it affects their number of ran clinical trials, R&D spending, and share prices.

Read More
Apr 2023

Global Impact of COVID-19 Pandemic on Clinical Trials

By |2023-04-20T12:38:49+02:00April 19, 2023|Blog, News|Comments Off on Global Impact of COVID-19 Pandemic on Clinical Trials

Wondering how the COVID-19 pandemic has impacted clinical trials worldwide? The COVID-19 pandemic has brought unprecedented challenges to the healthcare industry worldwide. The clinical trial sector has been no exception, and it has undergone significant changes over the past few years. From the [...]

Read More
Go to Top